{"filing":{"accession_number":"0001683168-26-006608","cik":"0001367083","ticker":"SNOA","company_name":"Sonoma Pharmaceuticals, Inc.","form":"8-K","filing_date":"2026-08-19","report_date":"2026-08-19","primary_document":"sonoma_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316826006608/sonoma_8k.htm"},"events":[{"id":28623,"run_id":26191,"accession_number":"0001683168-26-006608","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.85,"summary":"Item 5.07 requires disclosure of shareholder vote results. Although this filing reports a failed quorum rather than completed voting results, it discloses the outcome of a stockholder meeting submission — specifically that the adjourned Special Meeting on August 19, 2026 lacked the required quorum (1,157,852 shares needed; only 3,473,554 shares outstanding) and was cancelled without further proxy solicitation. This is a material governance event affecting the Company's ability to conduct shareholder business.","company_name":"Sonoma Pharmaceuticals, Inc.","ticker":"SNOA","filing_date":"2026-08-19","form":"8-K","submitted_at":null,"items":[{"id":30624,"accession_number":"0001683168-26-006608","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"Item 5.07 requires disclosure of shareholder vote results. Although this filing reports a failed quorum rather than completed voting results, it discloses the outcome of a stockholder meeting submission — specifically that the adjourned Special Meeting on August 19, 2026 lacked the required quorum (1,157,852 shares needed; only 3,473,554 shares outstanding) and was cancelled without further proxy solicitation. This is a material governance event affecting the Company's ability to conduct shareholder business.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-19T21:28:39.388600+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":30624,"accession_number":"0001683168-26-006608","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"Item 5.07 requires disclosure of shareholder vote results. Although this filing reports a failed quorum rather than completed voting results, it discloses the outcome of a stockholder meeting submission — specifically that the adjourned Special Meeting on August 19, 2026 lacked the required quorum (1,157,852 shares needed; only 3,473,554 shares outstanding) and was cancelled without further proxy solicitation. This is a material governance event affecting the Company's ability to conduct shareholder business.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-19T21:28:39.388600+00:00","company_name":"Sonoma Pharmaceuticals, Inc.","ticker":"SNOA","filing_date":"2026-08-19"}]}